Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

References

Page 1

	Year	Citations
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays Yifang Hu, Gordon K. Smyth Journal of Immunological Methods Functional GenomicsOther AssaysDilution AnalysisGeneticsStem Cells	2009	2.1K
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas Dong Fang, Thiennga K. Nguyen, Kim Leishear, Cancer Research	2005	1.3K
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth Alexander Roesch, Mizuho Fukunaga‐Kalabis, E C Schmidt, Cell Temporarily Distinct SubpopulationSlow-cycling Melanoma CellsSkin CancerContinuous Tumor GrowthMedicine	2010	1.2K
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Timothy R. Wilson, Jane Fridlyand, Yibing Yan, Nature MedicineKinase InhibitorsAnti-cancer AgentPharmacologyCancer Growth	2012	1.1K
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Cancer Research Tumor BiologyC-met KinaseChemoprevention StrategyNovel TherapyMedicine	2007	746
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized Elsa Quintana, Mark Shackleton, Hannah R. Foster, Cancer Cell Hierarchically OrganizedTumor HeterogeneityMedicineMelanomaPathology	2010	595
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target Chenwei Li, Jingjiang Wu, Mark J. Hynes, Gastroenterology Tumor BiologyOncologyPancreatic CancerMedicinePathology	2011	384
c-MET as a potential therapeutic target and biomarker in cancer J. Rafael Sierra, Ming‐Sound Tsao Therapeutic Advances in Medical Oncology Potential Therapeutic TargetMedicinePharmacologyImmunologyPathology	2011	354
BindingDB Entry 50022503: A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase. PubMed	2025	235
Phenformin enhances the therapeutic benefit of BRAF <sup>V600E</sup> inhibition in melanoma Ping Yuan, Koichi Ito, Rolando Pérez‐Lorenzo, Proceedings of the National Academy of Sciences	2013	220

Page 1